Daiken Medical Co., Ltd. provided non-consolidated earnings guidance for the Six months ending September 30, 2023 and full yearMarch31, 2024. For the period, the company expects Net sales of JPY 4,650million, Operating profit of JPY 550 million, Profit of JPY 380 million and Earnings per share of JPY 13.23.

For the period, the company expects Net sales of JPY 9,600million, Operating profit of JPY1,300 million, Profit of JPY 900 million and Earnings per share of JPY 31.33.